Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,713 total articles
Coeur Mining (CDE) rallied off its 2025 lows but technical momentum and valuation compression suggest the easy money may be gone. With gold under pressure, elevated short activity, and mixed fundamentals, a disciplined short with a tight stop and mid-term target offers asymmetric risk/reward.
Taiwan Semiconductor (TSM) is positioned to benefit disproportionately from accelerating AI chip demand and capacity tightness. Fundamentals and technicals support a long trade: enter at $451.35, stop at $420.00, target $490.00 over a long-term horizon (180 trading days). The valuation is elevated but not excessive given TSM's market share and capi…
Abercrombie & Fitch is seeing a real momentum shift at the core Abercrombie brand and Hollister, with consecutive sales growth, rising earnings revisions, and attractive valuation. I outline a mid-term long trade (45 trading days) with entry at $135.71, target $155.00 and stop $122.00, plus catalysts and a balanced risk framework.
UMAC has retreated from its late-summer high and is trading near key moving averages. With a $1.2B market cap, negative free cash flow but improving trading momentum and a policy-driven industry backdrop, this is a tactical accumulation trade: buy into a correction around $23.70, use a protective stop below $19.00 and target $34.00 over the next 18…
United Therapeutics (UTHR) looks attractively priced for a long trade. The stock is trading well below its spring highs despite strong fundamentals: roughly $20.4B market cap, trailing EPS near $30.56, robust free cash flow of about $1.09B and virtually no net debt. Near-term technicals are weak, but upcoming regulatory catalysts and a defensible p…
IBM looks like a reset candidate rather than a high-flying growth story. The stock is trading below several short-term moving averages, has a reasonable P/E and strong free cash flow, and pays a healthy yield. This trade targets a mean-reversion into the $260 area over a 45-trading-day swing if the market accepts that IBM's legacy businesses will s…
Carvana has moved from survival to scalable profitability. Strong ROE, meaningful free cash flow, a healthy liquidity profile and an expanding product set (including new-car retail) justify paying up for shares. This trade idea buys that narrative near current levels with a clear stop and a 45-trading-day target tied to multiple expansion, not a on…
Assured Guaranty (AGO) trades at roughly $69.50, pricing in a trailing ROE near 6.2%. With a streamlined U.S. structure, a $324M free cash flow profile, low leverage and a sub-1x price-to-book, there is a credible path to a 10% ROE and a re-rating toward mid-teens P/E multiples. Trade plan: enter $69.50, stop $63.00, target $85.00 over a long-term …
Taiwan Semiconductor Manufacturing (TSM) is the backbone of modern AI silicon. With dominant market share, visible roadmap wins for A14, heavy capacity builds and a market cap north of $2.3 trillion, the stock looks attractively priced versus expected earnings growth. This trade targets a measured long with clear entry, stop and target aligned to s…
CoreWeave's sell-off has created a higher-conviction entry for patient, long-term traders. The company remains exposed to secular AI/GPU demand, capacity expansions, and a growing managed-services mix. We upgrade to a buy and lay out an actionable trade with clear entry, stop, and target levels for a long-term (180 trading days) horizon.
Nike is trading at multi-year lows with a $53B market cap, 17x trailing earnings, and a 4.6% dividend yield. Technicals show oversold conditions and a mild bullish MACD signal. With an upcoming catalyst runway (earnings, marketplace strategy and women's sports tailwinds), this trade targets a meaningful rebound while limiting downside with a clear …
Workday's improving margins, strong free cash flow and rapid AI ARR growth look underpriced at a $45.6B market cap. If ‘flex credits’ (a nascent monetization lever) gains traction and AI converts into recurring revenue, the stock should re-rate. Trade plan: enter $189.45, target $240.00, stop $165.00 over a 180-trading-day horizon.
Sandisk is benefiting from an AI-driven structural shift toward NAND flash in data centers. The stock has pulled back about 23% from its June peak even after record results and an extraordinary free cash flow profile. This trade targets a re-rating back toward peer-worthy multiples as hyperscaler demand sustains pricing - but it respects industry c…
Sezzle posted Q2 momentum — 76% active subscriber growth, 52% revenue growth and sub-six-month marketing payback — yet the stock trades at a modest premium to fundamentals. We view current weakness as a buying opportunity: enter at market, protect with a $95 stop, and target $140 over the next 45 trading days as catalysts re-rate the business.
Warrior Met Coal (HCC) is trading like a pure coal-price play while the company is delivering outsized volume and margin expansion. With Q1 revenue up ~53% and EBITDA up ~263% (operational beats and reaffirmed guidance), low leverage and an EV/EBITDA around 10.6, this is a re-rating trade: buy into improving unit economics and stable balance sheet,…
Encore Capital (ECPG) benefits from resilient U.S. collections and an attractive earnings multiple. With market cap near $2.09B, EPS at $14.22 and EV/EBITDA around 8.2x, the stock offers a mid-term trade backed by fundamentals and balance-sheet actions. We outline an entry, clear stop and a realistic target for a 45-trading-day horizon while mappin…
Mastercard is a clear beneficiary of secular shifts to digital payments, cross-border flows, and tokenized value. With FCF of $16.7B, a market cap near $497B and strategic moves into stablecoins and crypto rails, this trade targets a measured long exposure using a defined entry, stop and target over a 180-trading-day horizon.
Dycom (DY) dropped hard after margin weakness in its Communications segment despite record backlog and solid cash flow. The market's reaction has created an entry opportunity. I am starting a position with a clear stop and a long-term (180 trading days) target to capture mean reversion and backlog conversion.
Annexon is a clinical-stage biotech focused on C1q-driven neuroinflammation with two near-term programmatic catalysts and a market cap near $690M. The trade: initiate a long at $3.90, stop at $2.50, and target $6.50 over a long-term (180 trading days) horizon, sizing for binary Phase 3 outcomes and continued funding risk.
Legacy Education (LGCY) is showing the financial underpinnings and operational momentum that justify a rating upgrade. With no debt, solid cash generation, double-digit ROE, and EV/sales below 1.2, the stock looks mispriced relative to its ability to scale programs and absorb incremental student volume. We outline a concrete trade: enter at $9.46, …
Kadant (KAI) mixes engineered systems with a high-margin aftermarket business. Recent acquisitions and a cash-generative profile support an EBITDA multiple of 15.7x. We like a long trade on pullbacks: entry $274.00, target $320.00, stop $250.00, mid-term horizon (45 trading days).
Neutron Holdings (LIME) is the largest global shared micromobility operator, trading at a $1.90B market cap. Operational scale, improving unit economics and a reasonable PB ratio make LIME a buy for a long-term swing, but recent technicals and concentrated short activity argue for a phased entry and a clear stop.
PDD has been marked down while it pours capital into logistics, fulfillment and international expansion. At current levels the stock trades on a single-digit P/E, supportive technicals, and materially lower downside than the 52-week high suggests. This trade idea lays out an entry, stop and target for long-term traders willing to carry the investme…
Domino's Pizza Group (DPUKY) offers a compelling risk-reward for a mid-term swing trade. At $5.52 the stock yields roughly 4.18% and trades at a P/E of 13.3 on a market cap of about $1.06B. Technicals are neutral-to-slightly-bearish but the business generates steady cash flow from franchising and company-owned stores across the UK, Ireland and part…
Oscar Health has moved from growth-story skeptic to an earnings-beat narrative backed by outsized free cash flow, improving margins and analyst upgrades. The stock is trading below near-term technical resistance but offers an asymmetric risk/reward if membership and margin trends continue. This trade idea lays out entry, stop and target for a 45-tr…
